Drugs Made In America Acquisition Corp.
DMAA · XNASCIK 2028614fmd_0YASYVJ1YRFXHPVKAFPXKJFYQ4Finance, Insurance and Real Estate · Blank ChecksTemplate: Standard
Coverage: Jan 02, 2024 to Jun 30, 2026, 8 periods
Latest annual · FY2025
Millions- Operating income
- (3)
- Net income
- 6
Latest quarter · Q2 FY2026
Millions- Operating income
- (0)
- Net income
- 2
Drugs Made In America Acquisition Corp. (DMAA) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | Change | Source | |
|---|---|---|---|---|
| Operating income | -$2.8 million | 10-K 2026-04-15 · proof | ||
| Net income | $5.9 million | 10-K 2026-04-15 · proof | ||
| Cash from operating activities | -$539,187 | 10-K 2026-04-15 · proof | ||
| Total assets | $239.9 million | 10-K 2026-04-15 · proof | ||
| Total liabilities | $7.3 million | 10-K 2026-04-15 · proof | ||
| Cash and cash equivalents | $6,137 | 10-K 2026-04-15 · proof |
- What was Drugs Made In America Acquisition Corp. (DMAA)'s operating income in fiscal 2025?
- Drugs Made In America Acquisition Corp. (DMAA) reported operating income of -$2.8 million for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was Drugs Made In America Acquisition Corp. (DMAA)'s net income in fiscal 2025?
- Drugs Made In America Acquisition Corp. (DMAA) reported net income of $5.9 million for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What was Drugs Made In America Acquisition Corp. (DMAA)'s cash from operating activities in fiscal 2025?
- Drugs Made In America Acquisition Corp. (DMAA) reported cash from operating activities of -$539,187 for fiscal 2025 (the year ended Dec 31, 2025). Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are Drugs Made In America Acquisition Corp. (DMAA)'s total assets?
- As of Dec 31, 2025, Drugs Made In America Acquisition Corp. (DMAA) reported total assets of $239.9 million. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are Drugs Made In America Acquisition Corp. (DMAA)'s total liabilities?
- As of Dec 31, 2025, Drugs Made In America Acquisition Corp. (DMAA) reported total liabilities of $7.3 million. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
- What are Drugs Made In America Acquisition Corp. (DMAA)'s cash and cash equivalents?
- As of Dec 31, 2025, Drugs Made In America Acquisition Corp. (DMAA) reported cash and cash equivalents of $6,137. Source: the 10-K filed with the SEC on Apr 15, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:DMAA&period_type=annual&limit=5"Information only, not investment advice.